TriSalus Life Sciences, Inc. Investing Cash Flow
TriSalus Life Sciences, Inc. (TLSI) reported Investing Cash Flow of -$223.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- TriSalus Life Sciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$82.00K, a 188.17% decline year-over-year.
- TriSalus Life Sciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$141.00K.
- TriSalus Life Sciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$41.00K.
- TriSalus Life Sciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$176.00K.
- TriSalus Life Sciences, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$838.00K.
- TriSalus Life Sciences, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$345.00K.
- TriSalus Life Sciences, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$1.59M.
- TriSalus Life Sciences, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$1.79M, a 3076.67% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 4 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$223.00K 10-Q · filed 2026-08-06 | -$264.00K derived: sum of 3 quarters · filed 2026-08-06 | -$440.00K derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | -$141.00K 10-Q · filed 2026-05-12 | -$182.00K derived: sum of 2 quarters · filed 2026-05-12 | -$358.00K derived: sum of 3 quarters · filed 2026-05-12 | -$265.00K derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$217.00K derived: sum of 2 quarters · filed 2026-03-05 | -$124.00K derived: sum of 3 quarters · filed 2026-08-06 | -$838.00K 10-K · filed 2026-03-05 | |||||
| 2025-09-30 | -$176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$83.00K derived: sum of 2 quarters · filed 2026-08-06 | -$797.00K 10-Q · filed 2025-11-13 | -$847.00K derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$621.00K 10-Q · filed 2026-08-06 | -$671.00K derived: sum of 3 quarters · filed 2026-08-06 | -$840.00K derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | -$714.00K 10-Q · filed 2026-05-12 | -$764.00K derived: sum of 2 quarters · filed 2026-05-12 | -$933.00K derived: sum of 3 quarters · filed 2026-05-12 | -$993.00K derived: sum of 4 quarters · filed 2026-05-12 | |||||
| 2024-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$219.00K derived: sum of 2 quarters · filed 2026-03-05 | -$279.00K derived: sum of 3 quarters · filed 2026-03-05 | -$345.00K 10-K · filed 2026-03-05 | |||||
| 2024-09-30 | -$169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$229.00K derived: sum of 2 quarters · filed 2025-11-13 | -$295.00K 10-Q · filed 2025-11-13 | -$667.00K derived: sum of 4 quarters · filed 2025-11-13 | |||||
| 2024-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$126.00K 10-Q · filed 2025-08-12 | -$498.00K derived: sum of 3 quarters · filed 2025-08-12 | -$1.61M derived: sum of 4 quarters · filed 2025-08-12 | |||||
| 2024-03-31 | -$66.00K 10-Q · filed 2025-05-15 | -$438.00K derived: sum of 2 quarters · filed 2025-05-30 | -$1.55M derived: sum of 3 quarters · filed 2025-05-30 | -$1.58M derived: sum of 4 quarters · filed 2025-05-30 | |||||
| 2023-12-31 | -$372.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-05-30 | -$1.48M derived: sum of 2 quarters · filed 2025-05-30 | -$1.51M derived: sum of 3 quarters · filed 2025-05-30 | -$1.59M 10-K/A · filed 2025-05-30 | -$2.12M 10-K · filed 2024-04-11 | ||||
| 2023-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.14M derived: sum of 2 quarters · filed 2024-11-14 | -$1.22M 10-Q · filed 2024-11-14 | -$1.42M 10-Q · filed 2023-11-14 | -$1.49M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$104.00K 10-Q · filed 2024-08-14 | $8.12M 10-Q · filed 2023-08-02 | -$376.00K derived: sum of 3 quarters · filed 2024-08-14 | -$1.98M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$74.00K 10-Q · filed 2024-05-15 | -$234.41K 10-Q · filed 2023-05-12 | -$346.00K derived: sum of 2 quarters · filed 2024-05-15 | -$1.95M derived: sum of 3 quarters · filed 2024-05-15 | -$1.87M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11 | -$1.88M derived: sum of 2 quarters · filed 2024-04-11 | -$1.80M derived: sum of 3 quarters · filed 2024-04-11 | -$1.79M 10-K · filed 2024-04-11 | $233.20M 10-K · filed 2023-03-22 | ||||
| 2022-09-30 | -$1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.52M derived: sum of 2 quarters · filed 2023-11-14 | -$1.51M 10-Q · filed 2023-11-14 | $378.00K 10-Q · filed 2022-11-10 | |||||
| 2022-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $91.00K 10-Q · filed 2023-08-02 | |||||||
| 2022-03-31 | $11.00K 10-Q · filed 2023-05-12 | ||||||||
| 2021-12-31 | $60.00K 10-K · filed 2023-03-22 | ||||||||
| 2020-12-31 | -$250.00M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |